fda compounding semaglutide warning letters news issued 25 to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Drug Recalls and Warnings:

Individual results vary, but these figures represent what is achievable with consistent treatment and appropriate lifestyle support

If retatrutide has been left out of the fridge, the following steps are recommended: Note and document the time and ambient temperature of the excursion as accurately as possible this information will be needed by your trial coordinator or pharmacist Quarantine the product set it aside and do not use it until you have received guidance Contact your trial coordinator, prescribing clinician, or dispensing pharmacist before using or storing the product further

After stopping, the weight returns

It is not known whether either of these routes is currently available for retatrutide